4//SEC Filing
Kelly Paul Edward 4
Accession 0001213900-25-121968
CIK 0001553643other
Filed
Dec 15, 7:00 PM ET
Accepted
Dec 16, 9:28 AM ET
Size
5.5 KB
Accession
0001213900-25-121968
Insider Transaction Report
Form 4
Kelly Paul Edward
DirectorChief Operating Officer
Transactions
- Award
Stock Appreciation Rights
2025-12-12+828,000→ 828,000 totalExercise: $4.06From: 2026-03-12Exp: 2035-12-12→ Common Stock (828,000 underlying)
Footnotes (1)
- [F1]The stock appreciation rights vest in 16 equal quarterly installments commencing on March 12, 2026.
Documents
Issuer
RELMADA THERAPEUTICS, INC.
CIK 0001553643
Entity typeother
Related Parties
1- filerCIK 0001658544
Filing Metadata
- Form type
- 4
- Filed
- Dec 15, 7:00 PM ET
- Accepted
- Dec 16, 9:28 AM ET
- Size
- 5.5 KB